BioSpace News Archive

Optina, an innovative diagnostics company, leader in retinal imaging, brain health and systemic disease detection, announces the closing of an up to US$2.1M investment from the Alzheimer’s Drug Discovery Foundation (ADDF).

Advanced wound care items are intended to treat intense and ongoing wounds. Ongoing wounds invest in some opportunity to recuperate and are costly to treat.

Amoxicillin has gained popularity as an antibiotic in the primary care setting. Being an amino-penicillin, the antibiotic has generated widespread attention in the clinical fraternity for treating a range of gram-positive bacteria and some gram-negative bacteria.

The rising efforts by the pharmaceutical manufacturers and drug developers across the world on development of novel therapies aimed at treating various infectious diseases is one of the strongest motivators for the growth in the global antibiotics market in coming years.

The global Prefilled Syringes Market Size will be worth USD 9.11 Billion by 2027, according to a current analysis by Emergen Research.

BioAegis Therapeutics Inc., a clinical-stage, private company developing therapies for infectious, inflammatory and degenerative diseases based on a portfolio built around gelsolin technology, reports highlights from its recent shareholder meeting.

eFFECTOR Therapeutics, Inc. today announced multiple pipeline updates for its ongoing development programs.

GENFIT, a late-stage biopharmaceutical company dedicated to improving the lives of patients with severe chronic liver diseases, announced its provisional financial calendar for 2022.

Orphazyme A/S (ORPHA.CO; ORPH) (the “Company”), a late-stage biopharmaceutical company pioneering the Heat-Shock Protein response for the treatment of neurodegenerative orphan diseases, today announced that an Extraordinary General Meeting of the Company will be held on: Tuesday, February 15, 2022at 5:00 PM (CET).

As we have throughout the COVID-19 pandemic, the U.S. Food and Drug Administration has used the best available science as the virus has evolved to make informed decisions with the health and safety of the American public in mind.